🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 35104E100
- Market Cap
- Small Cap
- IPO
- 12/11/2020 · $23.00/share
Business: 4DMT is a clinical-stage gene therapy company pioneering the development of product candidates using targeted and evolved AAV vectors. 4DMT seeks to unlock the full potential of gene therapy.
Company Contact
- CEO
- David Kirn
- CFO
- Uneek Mehra
- Headquarters
- 5858 Horton Street #455, Emeryville, CA 94608
- Phone
- 510-505-2680
- Investor Relations
- Julian Pei · 510-505-2680 · Investor.Relations@4DMT.com